Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier.

Department of Environmental Science, Wuhan University, Wuhan, Hubei 430072, China.
Biomaterials (Impact Factor: 8.31). 01/2004; 24(27):5015-22. DOI: 10.1016/S0142-9612(03)00408-3
Source: PubMed

ABSTRACT N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (HTCC) is water-soluble derivative of chitosan (CS), synthesized by the reaction between glycidyl-trimethyl-ammonium chloride and CS. HTCC nanoparticles have been formed based on ionic gelation process of HTCC and sodium tripolyphosphate (TPP). Bovine serum albumin (BSA), as a model protein drug, was incorporated into the HTCC nanoparticles. HTCC nanoparticles were 110-180 nm in size, and their encapsulation efficiency was up to 90%. In vitro release studies showed a burst effect and a slow and continuous release followed. Encapsulation efficiency was obviously increased with increase of initial BSA concentration. Increasing TPP concentration from 0.5 to 0.7 mg/ml promoted encapsulation efficiency from 46.7% to 90%, and delayed release. As for modified HTCC nanoparticles, adding polyethylene glycol (PEG) or sodium alginate obviously decreased the burst effect of BSA from 42% to 18%. Encapsulation efficiency was significantly reduced from 47.6% to 2% with increase of PEG from 1.0 to 20.0 mg/ml. Encapsulation efficiency was increased from 14.5% to 25.4% with increase of alginate from 0.3 to 1.0 mg/ml.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Nanocarriers have shown tremendous potential for the target-specific delivery of proteins, genes and drugs. Nanoparticles are fabricated using different natural and synthetic polymers. Natural polysaccharides are often used as building block for developing nano-sized drug delivery vehicles. The physicochemical properties of these materials, such as excellent biocompatibility, low cytotoxicity, surface charges that interact with DNA, protein and RNA, and cost effectiveness, make them exceptional base materials for nanocarrier fabrication. The mechanism for the complex formation of polysaccharides-DNA includes the electrostatic interactions between cationic polymers and anionic DNA to form polyplexes that offer unique possibilities for overcoming cellular barriers by escaping endosomal trafficking followed by cellular internalization and, consequently, enhancing the efficacy of drug and macromolecule delivery to targeted cells and tissue. Depending upon the cellular uptake and trafficking, nanocarriers are designed for different pharmacological and therapeutic applications. However, specific targeting that improves delivery remains an unsolved challenged. The process by which nanocarriers enter cells has important consequences not only for fate of these particles but also for biological systems and therapeutic applications.
    Journal of Biomedical Nanotechnology 09/2014; 10(10):2149–2172. · 7.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, chitosan (CS) grafted by glycidyltrimethylammonium chloride (GTMAC) to form GTMAC-CS was synthesized, chemically identified, and rheologically characterized. The Maxwell Model can be applied to closely simulate the dynamic rheological performance of the chitosan and the GTMAC-CS solutions, revealing a single relaxation time pertains to both systems. The crossover point of G' and G" shifted toward lower frequencies as the CS concentration increased but remained almost constant frequencies as the GTMAC-CS concentration increased, indicating the solubility of GTMAC-CS in water is good enough to diminish influence from the interaction among polymer chains so as to ensure the relaxation time is independent of the concentration. A frequency-concentration superposition master curve of the CS and GTMAC-CS solutions was subsequently proposed and well fitted with the experimental results. Finally, the sol-gel transition of CS is 8.5 weight % (wt %), while that of GTMAC-CS is 20 wt %, reconfirming the excellent water solubility of the latter.
    Marine Drugs 11/2014; 12(11):5547-62. · 3.51 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The development of wide spectrum of drug delivery systems is fundamental importance to change the establishment of disease diagnosis, treatment and prevention. The fusion technologies of material science and nanomedicine have emerged as a new alternative and efficient field for transporting and translocating the therapeutic molecules. Biologically active materials can be functionalized with peptides, proteins, nucleic acids and drugs, and also be used as the delivery system to cell and organs. Today nanoscience and pharmaceutical technology approach to drug design and formulation to enhance the biological behavior and safety profile. Unique higher surface area, surface roughness, altered electron distribution, energetics and biological activity of standardized materials made a feasible role in therapeutics. Rationalized material, drug design and formulation will ensure the good clinical significance of the pharmaceutical product. This article will highlight the distinguished nanoscale biomaterial categorized by metal, non-metal, carbon, polymer, lipid, virus and miscellaneous nanostructures as nanobiopharmaceutical carrier systems and their medical/biological applications in the field of pharmaceutical sciences.


1 Download
Available from